Product Spotlight - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
Product Spotlight
Jan 1, 2013
Pharmaceutical Technology Europe

« Previous
12

Probe enables monitoring of in-process vacuum



Hiden Analytical's in-process vacuum monitor, the HALO 201 MBE, was initially designed for application to the molecular beam epitaxy process and is suitable for use in difficult process conditions. Many vacuum-related processes operate at high- or ultra-high vacuum levels that represent a difficult environment for quadrupole mass spectrometers, but the sensitive ionisation region of the HALO 201 MBE probe is completely shrouded to inhibit random surface deposition. With a mass range of 1–200 amu, the probe can be used for measuring all common gasses and contaminants, and features operating modes for vacuum species identification, leak detection, and process trend analysis.

Hiden Analytical
http://www.hidenanalytical.com
Sensor is available worldwide

Pressure transmitter for efficient manufacturing processes



Honeywell's SmartLine industrial pressure transmitters are designed to enhance communication abilities, improve operational efficiency and reduce lifecycle costs for process manufacturers. The transmitters are intended to make it easier to support field devices and promote plant reliability with their efficiency-enhancing features, such as a graphic display capable of showing process data in graphical formats and communicating messages from the control room. SmartLine transmitters also feature modular components to simplify field repairs and reduce inventory required to make such repairs.

Honeywell Process Solutions
http://www.honeywellprocess.com/
Transmitters are available worldwide

« Previous
12

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
14%
To select process for new products only
23%
To select processes for both new and legacy products
20%
Do not use QbD
25%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
FindPharma Custom Search
Featured Jobs

More Jobs
Source: Pharmaceutical Technology Europe, 1/1/2013
 Click here